Advertisement
Advertisement
Arexvy

Arexvy Indications/Uses

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
The use of this vaccine should be in accordance with official recommendations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement